Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia.
about
Role of Hybrid Brain Imaging in Neuropsychiatric DisordersAmyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's diseaseNeuroimaging biomarkers of neurodegenerative diseases and dementiaAtrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trialsDifferences in functional brain connectivity alterations associated with cerebral amyloid deposition in amnestic mild cognitive impairmentPET amyloid-beta imaging in preclinical Alzheimer's diseaseClassification of amyloid-positivity in controls: comparison of visual read and quantitative approaches.The role of hippocampal iron concentration and hippocampal volume in age-related differences in memory.APOE ε4 genotype predicts memory for everyday activitiesCortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET dataAdvances in MRI biomarkers for the diagnosis of Alzheimer's disease.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Basal Forebrain Atrophy Contributes to Allocentric Navigation Impairment in Alzheimer's Disease PatientsRecent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.Association of gray matter atrophy with age, β-amyloid, and cognition in agingSteady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sexTime to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's DiseaseSelective disruption of the cerebral neocortex in Alzheimer's diseaseProtein aggregation containing β-amyloid, α-synuclein and hyperphosphorylated τ in cultured cells of hippocampus, substantia nigra and locus coeruleus after rotenone exposure.In vivo human amyloid imaging.β-Amyloid is associated with aberrant metabolic connectivity in subjects with mild cognitive impairment.Structural imaging in early pre-states of dementia.Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volumeRole of structural MRI in Alzheimer's diseaseBrain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's diseaseShould we disclose amyloid imaging results to cognitively normal individuals?A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study.Differential effects of age and history of hypertension on regional brain volumes and iron.Enrichment and stratification for predementia Alzheimer disease clinical trials.Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects.A review of neuroimaging biomarkers of Alzheimer's disease.β-Amyloid affects frontal and posterior brain networks in normal aging.Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease.Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment.Iatrogenic risk factors for Alzheimer's disease: surgery and anesthesia.Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.
P2860
Q26768454-CDE1DD2E-4217-4300-ACA8-20BB7818B4D9Q27009411-33C9852E-C63B-49B0-AE92-AA1E8086C40FQ27691820-73F12AA5-9371-46E2-8C24-C4CB2DE69DC7Q28488143-C44FDBC4-3DA4-4D14-AF55-729B950CEC8DQ28649713-B2B1756B-43A3-4A41-93F6-A9B244FB3801Q30040695-6FFE5E14-6A91-4E10-98C7-DF4B7D1D4472Q30413572-986AB984-A8DB-4A84-B310-EFCC7C9793F5Q30540311-4476376F-0177-4C13-B3FD-245DF707505AQ30661353-AB83691F-2422-4B0B-AA32-4A8B086C3B8AQ30722226-4582CFF7-B7E2-4E8C-A2B6-68A4FACBE101Q30870223-466AA4DD-2507-402C-88F0-56C532F881FDQ30971403-419564ED-0752-4840-9C54-1C8A78BCD190Q31002137-000F691E-6C3F-4530-9C29-8B74BD28303BQ33556068-0C6F0E94-22B2-4D1D-B5E5-A7B35BAE1F29Q33582714-7FC71923-B96F-442B-9970-2EE910549EC5Q33683890-18CA9DFB-BFFD-402A-99C6-4FA5858678F9Q33695122-905E5D6E-9487-4359-8999-39F9ACA95F63Q33707724-AB454A21-684E-49A2-B187-C7D65201A98CQ33743531-9E571E5E-D964-4A1A-AA37-C40FBA286713Q33790277-CBB9778B-84EF-4555-9385-125EC8B2E36AQ33851470-710DEBC0-6F17-4B01-BCE8-D7E959B31978Q33967561-E46A77AB-C724-438B-A5CB-E6BCB69EDB64Q33998690-58E22788-51DD-4852-900D-A4BD91E2AF25Q34013887-DFCC41D1-D472-4144-8DAB-CFDC6541E125Q34101122-F0212F4F-DBA7-4A39-9DE9-13F62F94BF5AQ34173192-A7C68537-7F35-4E91-8BC7-F79FD2CC2806Q34247849-4902DA15-BDA0-46D6-B8AF-18A26D2D7BA0Q34286140-75487780-6672-46DD-AA27-17111D734E78Q34341870-6BEB1348-99F7-497E-8929-99839FD8EF40Q34380735-E1CF2BB9-45E6-48C6-8DAC-EED9B1BC9FA1Q34452239-F77AA361-1CEB-4B80-AED3-0E16FB593949Q34459137-0A99BDC7-0B5F-496C-BC38-30D6BC2070DFQ34498348-1145DCA8-1FFA-4910-AF6A-7893F28D4133Q34571189-48EA0B8C-1A5C-4074-9F50-E3E0B154A55AQ34572447-BDCA7A55-95BC-446E-8B6C-6B888F5C9541Q34601458-585DA064-1CF3-4C7A-BB8A-6A5F4022C9BCQ34606557-519518B7-4430-4A3F-A1EA-82458C3EC078Q34754658-C98F7250-502E-4A04-999C-A71D5BE929BFQ35024855-3CB82E93-A697-4CCA-BBB7-455037BCA8BBQ35031724-2077F1B0-A32B-4B99-B704-5A93E8A52AB1
P2860
Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Beta-amyloid burden in the tem ...... rly subjects without dementia.
@en
Beta-amyloid burden in the tem ...... rly subjects without dementia.
@nl
type
label
Beta-amyloid burden in the tem ...... rly subjects without dementia.
@en
Beta-amyloid burden in the tem ...... rly subjects without dementia.
@nl
prefLabel
Beta-amyloid burden in the tem ...... rly subjects without dementia.
@en
Beta-amyloid burden in the tem ...... rly subjects without dementia.
@nl
P2093
P50
P1433
P1476
Beta-amyloid burden in the tem ...... rly subjects without dementia.
@en
P2093
AIBL Research Group
C L Masters
G Chételat
R N Martins
S Ourselin
V L Villemagne
P304
P356
10.1212/WNL.0B013E3181C918B5
P407
P577
2010-01-01T00:00:00Z